Sarcomas as a Paradigm for Personalized Medicine and Targeted Therapies: New Directions and Innovative Approaches to Diagnosis and Treatments

Chicago Marriott Downtown Magnificent Mile
June 1, 2008 .
Not an official event of the 2008 American Society of Clinical Oncology (ASCO) Annual Meeting. Not sponsored or endorsed by ASCO or The ASCO Foundation.
Acknowledgement of Commercial Support
The CBCE and Sarcoma Foundation of America gratefully acknowledge the educational grant provided by: ARIAD Pharmaceuticals, Inc.; Novartis Oncology; Pfizer; PharmaMar, S.A.; Roche Pharmaceuticals; Infinity Pharmaceuticals, Inc.; Daiichi Sankyo Pharma Development; EMD Serono, Inc.; and IDM Pharma

ASCO 2008 , Pharma Mar y J&J en el Scientific Program Committee Disclosure Index .

Pagina 3 J&J Y Pharma Mar en Developmental Therapeutics–Cytotoxic Chemotherapy .
Pagina 7 Pharma Mar en Genitourinary Cancer .
Pagina 8 J&J en Gynecologic Cancer .
Pagina 12 J&J en Sarcoma .